目的探讨无抗凝血液滤过技术在有高危出血风险的危重患者中应用的安全性和有效性。
Objective To explore the safety and therapeutic efficacy of hemofiltration without anticoagulation in critically ill patients at high risk of bleeding.
结论CVVH中应用无肝素抗凝技术同样高效、稳定、安全，对于高危出血患者，是保障CVVH治疗持续进行的重要措施。
Conclusion Anticoagulation without heparin is high efficient, stable and safe. It is an important measure to ensure CVVH continuously for patients with high risk of bleeding.
应用推荐